Your browser does not support JavaScript! FENTANYL CITRATE, BUPIVACAINE HCL INJECTION, SOLUTION [CANTRELL DRUG COMPANY]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

FENTANYL CITRATE, BUPIVACAINE HCL injection, solution
[Cantrell Drug Company]


Category DEA Schedule Marketing Status
HUMAN PRESCRIPTION DRUG LABEL CII unapproved drug other
NOTE:THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND EFFECTIVE, AND THIS LABELING HAS NOT BEEN APPROVED BY FDA. For further information about unapproved drugs, click here.
Drug Label Sections

Label

MM1

FENTANYL CITRATE, BUPIVACAINE HCL 
fentanyl citrate, bupivacaine hcl injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:52533-080
Route of AdministrationEPIDURALDEA ScheduleCII    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Fentanyl Citrate (Fentanyl) Fentanyl2 ug  in 1 mL
BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE) BUPIVACAINE1.25 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
Sodium Chloride9 mg  in 1 mL
Water 
Packaging
#Item CodePackage Description
1NDC:52533-080-61250 mL in 1 BAG
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other08/16/2012
Labeler - Cantrell Drug Company (035545763)

Revised: 10/2012
Document Id: abea8ad3-e77e-4fd7-a4ec-d4539577e231
Set id: cfecc5f4-5ce0-46d5-b1d4-92654246fcb2
Version: 3
Effective Time: 20121002
 
Cantrell Drug Company

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services